This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Jul 2012

China's Healthcare Reforms Offer Opportunities for Global Pharma

China's massive investment in healthcare presents significant opportunities for pharmaceutical companies around the world.

China's government is in the process of implementing major healthcare reforms which should dramatically improve the provision of services for the nation's 1.3 billion citizens, a new report has said.


Thanks to $180 billion worth of investment announced back in 2009, changes are occurring in five key areas, according to's latest market research report, entitled 'Inside China's Healthcare Reforms: Opportunities for Multinational Pharma'.


These are the expansion of medical insurance coverage; the creation of a national essential drug list; investment in primary healthcare facilities; more equal distribution of healthcare provision; and public hospital pilot schemes.


As a result of

Related News